About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Alzheimer's Disease Clinical Trials in Houston | 155 Studies

Clinical Trials Alzheimer's DiseaseHouston

Alzheimer's Disease Clinical Trials in Houston

Find 155 clinical trials for alzheimer's disease near Houston, Texas. Connect with research centers in your area.

All Alzheimer's Disease trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 61-80 of 155 trials

Enrolling by invitationAlzheimer's Disease Neuroimaging Initiative 4The Alzheimer's Disease Neuroimaging Initiative 4 (ADNI4) is a non-randomized, longitudinal, natural history study designed to validate biomarkers, improve clinical trial design…NCT05617014·Birmingham, Alabama and 64 others

Alzheimer's Disease Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedA Study of Mevidalen (LY3154207) in Participants With Alzheimer's DiseaseThe main purpose of this study is to look at how safe the study drug (mevidalen) is and whether it works to alleviate symptoms when given to people with mild to moderate Alzheimer…NCT06538116·Phoenix, Arizona and 63 others

CompletedGAIN Trial: Phase 2/3 Study of COR388 in Subjects With Alzheimer's DiseaseThis is a randomized, double-blind, placebo-controlled study that assessed the efficacy, safety, and tolerability of 2 dose levels of COR388 in subjects with a clinical diagnosis…NCT03823404·Phoenix, Arizona and 92 others

CompletedSafety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)The purpose of this study is to evaluate the long-term safety of AVP-923 in the treatment of Involuntary Emotional Expression Disorder (IEED) also known as Pseudobulbar Affect…NCT00056524·Phoenix, Arizona and 38 others

TerminatedAD-4833/TOMM40_303 Extension Study of the Safety and Efficacy of Pioglitazone to Slow Cognitive Decline in Participants With Mild Cognitive Impairment Due to Alzheimer DiseaseThe purpose of this study is to evaluate the effect of pioglitazone at 24 months compared with placebo on cognitive decline in high-risk participants who have completed the…NCT02284906·Phoenix, Arizona and 42 others

RecruitingEpidemiology and Biomarker Study in Alzheimer's DiseaseStudy AACU determines rates of cognitive worsening in participants within elevated and not elevated plasma P-tau217 cohorts. Participation in AACU will last approximately 7 years.NCT07142954·Houston, Texas and 3 others

RecruitingA Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)Researchers want to know if the study treatment called MK-2214 works to slow certain changes in the brains of people with Alzheimer's disease (AD).NCT07033494·Irvine, California and 79 others

Active not recruitingHead-to-Head Harmonization of Tau Tracers in Alzheimer's DiseaseThe purpose of this study is to compare/harmonize cross-sectional and longitudinal tau tangle measurements obtained with the tau PET radiopharmaceuticals Flortaucipir and MK-6240…NCT05361382·Berkeley, California and 8 others

CompletedSafety and Efficacy of Tafamidis in Patients With Transthyretin CardiomyopathyThis Phase 3 study will investigate the efficacy, safety and tolerability of an oral daily dose of 20 mg or 80 mg tafamidis meglumine capsules compared to placebo in subjects with…NCT01994889·Birmingham, Alabama and 79 others

Active not recruitingStudy to Evaluate the Efficacy, Safety, and Tolerability of an Anti-MTBR Tau Monoclonal Antibody (BMS-986446) in Participants With Early Alzheimer's DiseaseThe purpose of this study is to assess the effectiveness, safety, and tolerability of BMS-986446 an Anti-MTBR Tau Monoclonal Antibody in participants with Early Alzheimer's…NCT06268886·Chandler, Arizona and 175 others

TerminatedA Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's DiseaseThe main purpose of this study is to investigate the safety and efficacy of the study drug solanezumab in participants with prodromal Alzheimer's disease (AD).NCT02760602·Phoenix, Arizona and 192 others

CompletedStudy Evaluating the Safety, Tolerability, and Efficacy of Lecozotan SR in Outpatients With Alzheimer's DiseaseThe purpose of the study is to determine the safety, tolerability, and efficacy of 3 doses of lecozotan in combination with a cholinesterase inhibitor in patients with mild to…NCT00277810·Phoenix, Arizona and 82 others

TerminatedA Study of JNJ-63733657 in Participants With Early Alzheimer's DiseaseThe primary purpose of this study is to evaluate the effect of JNJ-63733657 versus placebo on clinical decline as measured by the Integrated Alzheimer's Disease Rating Scale…NCT04619420·Birmingham, Alabama and 121 others

UnknownEvidence Amyloid Scan EEG StudyThe Evidence Amyloid Study EEG (EASE) establishes an open-label, longitudinal cohort study to measure of neurological functioning during the onset and progression of cognitive…NCT03644043·Houston, Texas

TerminatedHome-based tDCS for Apathy in Alzheimer's DiseaseThe purpose of this study is to assess feasibility, acceptability, and safety of providing tDCS to Alzheimer's disease and related dementias (ADRD) patients with apathy and to…NCT04855643·Houston, Texas

Active not recruitingA Study of Trontinemab in Participants With Early Symptomatic Alzheimer's DiseaseThe purpose of this study is to assess the efficacy and safety of trontinemab in participants with early symptomatic Alzheimer's disease (AD) (mild cognitive impairment \[MCI\] to…NCT07169578·Birmingham, Alabama and 141 others

CompletedStudy of Melatonin: Sleep Problems in Alzheimer's DiseaseThis protocol is a multicenter clinical trial of melatonin for sleep disturbances associated with Alzheimer's disease (AD).NCT00000171·Tucson, Arizona and 30 others

TerminatedStudy of PRX-03140 Monotherapy in Subjects With Alzheimer's DiseaseA randomized placebo-controlled study to evaluate the efficacy of PRX-03140 monotherapy in subjects with Alzheimer's disease.NCT00693004·Phoenix, Arizona and 32 others

CompletedA Study to Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)The primary purpose of this study is to evaluate the effect of SAGE-718 on cognitive performance in participants with Alzheimer's Disease.NCT05619692·Gilbert, Arizona and 38 others

CompletedEfficacy and Safety of Ramelteon in Subjects With Mild to Moderate Alzheimer's DiseaseThe purpose of this study is to determine the efficacy of ramelteon, once daily (QD), in subjects with mild to moderate Alzheimer's Disease and sleep disturbanceNCT00325728·Alabaster, Alabama and 71 others

PreviousPage 4 of 8Next

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia